Galapagos NV (GLPG)
Galapagos and Gilead in Advanced Discussions to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases
Galapagos and Gilead in Advanced Discussions to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases
📈 **POSITIVE** • Medium confidence analysis (67%) • Strong positive catalyst • High growth potential **Sentiment:** Positive (95%) **Content type:** General